Does Dr. GLADYS SEEHAM have financial conflicts of interest?

Dr. GLADYS SEEHAM (APN-CNP) has received a total of $1,340 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,340 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. GLADYS SEEHAM?

According to CMS Open Payments data, Dr. GLADYS SEEHAM received funding from ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($278), JANSSEN PHARMACEUTICALS ($239), and NOVARTIS PHARMACEUTICALS CORPORATION ($170).

Does Dr. GLADYS SEEHAM receive research grants or speaking fees?

Dr. GLADYS SEEHAM has received $1,340 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. GLADYS SEEHAM

APN-CNPReal-Time Hydrated

Specialty: Nurse Practitioner

Practice Location: EVANSTON, IL 60201

NPI Number: 1508318148

LIFETIME INDUSTRY VALUE

$1,340

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. SEEHAM is a verified Nurse Practitioner practitioner based in EVANSTON, IL.

Between 2021 and 2025, Dr. SEEHAM had an overall industry promotional and research financial footprint of $1,340 as recorded in the federal CMS Open Payments database.

$1,340 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. SEEHAM's primary funding source is ZOLL SERVICES (A/K/A ZOLL LIFECOR ), which accounts for $278 (representing 20.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 1

$278

20.8%

JANSSEN PHARMACEUTICALS

Rank 2

$239

17.8%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 3

$170

12.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.